Strategic DPI partnership Leverage 3P innovation's recent DPI manufacturing initiatives and strategic partnerships with Mikron Automation to position and offer integrated Dry Powder Inhaler manufacturing solutions to pharmaceutical and device manufacturers seeking end-to-end automation in sterile or high-precision dosing.

Global expansion signals Corporation activity in the UK and Switzerland, plus a history of scaling facilities in the US, indicates a readiness to serve multinational pharma clients with localized automation deployments and after-sales support across regions.

Niche automation capabilities Expertise in high-precision liquid and powder filling systems, jaw versus rotary crimping analyses, and DPI device integration suggests opportunities to upsell to manufacturers needing specialized filling, crimping, and format-flexible packaging lines.

Financial and growth momentum Revenue range of several tens of millions and a track record of rapid growth, combined with notable training and workforce investments, signals capacity to take on larger projects with robust program management and long-term service agreements.

Sustainability and compliance focus Prior investments in eco-friendly facilities and a history of delivering compliant, scalable processes align with pharma and device customers prioritizing quality, regulatory readiness, and sustainable manufacturing practices.